Cargando…

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Patients after Acute Stroke: Relation to Stroke Severity, Myocardial Injury, and Impact on Prognosis

Background: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is known to be associated with poor prognosis after cardiovascular events. We aimed to assess the dynamic changes in TRAIL levels and the relation of TRAIL level to stroke severity, its impact on the short-term outcomes, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mihalovic, Michal, Mikulenka, Petr, Línková, Hana, Neuberg, Marek, Štětkářová, Ivana, Peisker, Tomáš, Lauer, David, Tousek, Petr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103556/ https://www.ncbi.nlm.nih.gov/pubmed/35566677 http://dx.doi.org/10.3390/jcm11092552

Ejemplares similares

Prevalence of myocardial injury in patients after acute ischaemic stroke according to standard criteria
por: Mihalovic, Michal, et al.
Publicado: (2023)

Myocardial Injury after Stroke
por: Mihalovic, Michal, et al.
Publicado: (2021)

Clinical and radiological factors predicting stroke outcome after successful mechanical intervention in anterior circulation
por: Peisker, Tomáš, et al.
Publicado: (2022)

Direct transfer of acute stroke patients to angiography suites equipped with flat-detector computed tomography: literature review and initial single-centre experience
por: Sulženko, Jakub, et al.
Publicado: (2022)

Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients
por: Osmancik, Pavel, et al.
Publicado: (2013)

The importance of interdisciplinary research
por: Widimsky, Petr, et al.
Publicado: (2023)

Intravascular haemolysis after transcatheter aortic valve implantation with self-expandable prosthesis: incidence, severity, and impact on long-term mortality
por: Širáková, Andrea, et al.
Publicado: (2020)

Partial upper sternotomy for aortic valve replacement provides similar mid-term outcomes as the full sternotomy
por: Hlavicka, Jan, et al.
Publicado: (2022)

Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Klancik, Viktor, et al.
Publicado: (2022)

Acute ischaemic stroke: recent advances in reperfusion treatment
por: Widimsky, Petr, et al.
Publicado: (2022)

Influence of Hyperglycaemia and CRP on the Need for Mechanical Ventilation in Guillain-Barré Syndrome
por: Štětkářová, Ivana, et al.
Publicado: (2022)

Pharmacodynamic Effect of Clopidogrel in Patients Undergoing Transcatheter Aortic Valve Implantation
por: Tousek, Petr, et al.
Publicado: (2013)

Comparison of a Bioresorbable, Magnesium-Based Sirolimus-Eluting Stent with a Permanent, Everolimus-Eluting Metallic Stent for Treating Patients with Acute Coronary Syndrome: the PRAGUE-22 Study
por: Toušek, Petr, et al.
Publicado: (2021)

Might simplification of transcatheter aortic valve implantation reduce the burden on hospital resources?
por: Kratochvílová, Lenka, et al.
Publicado: (2022)

Triggers, characteristics, and hospital outcome of patients with Takotsubo syndrome: 10 years experience in a large university hospital centre
por: Polednikova, Karolina, et al.
Publicado: (2023)

Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
por: Teringova, Elena, et al.
Publicado: (2018)

Pre-hospital delay, clinical characteristics, angiographic findings, and in-hospital mortality in young and middle-aged adults with acute coronary syndrome: a single-centre registry analysis
por: Bauer, Dávid, et al.
Publicado: (2023)

Predictors allowing early discharge after interventional treatment of acute coronary syndrome patients
por: Bauer, Dávid, et al.
Publicado: (2022)

Patient characteristics, treatment strategy, outcomes, and hospital costs of acute coronary syndrome: 3 years of data from a large high-volume centre in Central Europe
por: Toušek, Petr, et al.
Publicado: (2022)

Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension
por: Hameed, Abdul G., et al.
Publicado: (2012)

Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
por: Elmallah, Mohammed I. Y., et al.
Publicado: (2015)

Synthetic Flavanones Augment the Anticancer Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
por: Szliszka, Ewelina, et al.
Publicado: (2012)

The Coumarin Psoralidin Enhances Anticancer Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
por: Bronikowska, Joanna, et al.
Publicado: (2012)

Fully automated measurement of aortic root anatomy using Philips HeartNavigator computed tomography software: fast, accurate, or both?
por: Kočka, Viktor, et al.
Publicado: (2022)

Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence
por: Koliaki, Chrysi, et al.
Publicado: (2022)

Myocardial infarction caused by compression of the left coronary artery by an aortic pseudoaneurysm
por: Roček, Jan, et al.
Publicado: (2020)

Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 Pandemic
por: Toušek, Petr, et al.
Publicado: (2020)

Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression
por: Song, Kaimei, et al.
Publicado: (2000)

Dietary Flavonoids Sensitize HeLa Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
por: Szliszka, Ewelina, et al.
Publicado: (2008)

Interactions of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) with the Immune System: Implications for Inflammation and Cancer
por: Beyer, Katharina, et al.
Publicado: (2019)

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells
por: Potu, Harish, et al.
Publicado: (2019)

Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL
por: Griffith, Thomas S., et al.
Publicado: (1999)

Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression
por: Vigneswaran, Nadarajah, et al.
Publicado: (2007)

Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail)
por: Fanger, Neil A., et al.
Publicado: (1999)

Nurse-led sedation for transfemoral transcatheter aortic valve implantation seems safe for a selected patient population
por: Kočka, Viktor, et al.
Publicado: (2022)

Targeted expression of tumor necrosis factor-related apoptosis-inducing ligand TRAIL in skin protects mice against chemical carcinogenesis
por: Kedinger, Valerie, et al.
Publicado: (2011)

Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol
por: Brombo, Gloria, et al.
Publicado: (2013)

Characterization of the Role of Tumor Necrosis Factor Apoptosis Inducing Ligand (TRAIL) in Spermatogenesis through the Evaluation of Trail Gene-Deficient Mice
por: Lin, Yi-Chen, et al.
Publicado: (2014)

Nanotechnology in Stroke: New Trails with Smaller Scales
por: Toljan, Karlo, et al.
Publicado: (2023)

Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study ‘Prague 19’
por: Kočka, Viktor, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h2hc9pnaec66v14so7dednra2s